Conray 35
Conray 35 Brand names, Conray 35 Analogs
- Acide amidotrizoique
- Acidum amidotrizoicum
- Acidum diacetylaminotrijodbenzoicum
- AmiDOTrizoic acid
- Amidotrizoate
- Angiovist 282
- Cardiografin
- Conray 35
- DIAT [German]
- Diat
- Diatriazoate
- Diatrizoate sodium
- Diatrizoate sodium salt
- Diatrizoesaeure
- Diatrizoesaure
- Diatrizoesaure [German]
- Diatrizoic acid
- Diatrizoic acid [USAN:BAN]
- Diatrizoic acid sodium salt
- Gastrografin
- Hypaque
- Hypaque 50
- Hypaque sodium
- Iothalamate
- Meglumine diatrizoate
- Methalamic acid
- Odiston
- Reno-dip
- Renografin 76
- Sodium amidotrizoate
- Sodium diatrizoate
- Triombrin
- Triombrin [Russian]
- Triombrine
- Urografic acid, sodium salt
- Urografin acid
- Urogranoic acid
- Urotrast
- Urovison
- Urovist Cysto
- Urovist Cysto Pediatric
- Urovist Meglumine Diu/ct
- Urovist Sodium 300
- Vascoray
Conray 35 Brand Names Mixture
- No information avaliable
Conray 35 Chemical_Formula
C9H15N5O3
Conray 35 RX_link
No information avaliable
Conray 35 fda sheet
Conray 35 msds (material safety sheet)
Conray 35 Synthesis Reference
No information avaliable
Conray 35 Molecular Weight
241.247 g/mol
Conray 35 Melting Point
250-255 oC (hydrochloride salt)
Conray 35 H2O Solubility
>20 mg/mL (dichloride salt)
Conray 35 State
Solid
Conray 35 LogP
-1.783
Conray 35 Dosage Forms
No information avaliable
Conray 35 Indication
For the treatment of tetrahydrobiopterin (BH4) deficiency.
Conray 35 Pharmacology
Tetrahydrobiopterin (BH4) is used to convert several amino acids, including phenylalanine, to other essential molecules in the body including neurotransmitters. Tetrahydrobiopterin deficiency can be caused by mutations in GTP cyclohydrolase 1 (GCH1), 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (PCBD1), 6-pyruvoyltetrahydropterin synthase (PTS), and quinoid dihydropteridine reductase (QDPR) genes. These genes make the enzymes that are critical for producing and recycling tetrahydrobiopterin. If one of the enzymes fails to function correctly because of a gene mutation, little or no tetrahydrobiopterin is produced. As a result, phenylalanine from the diet builds up in the bloodstream and other tissues and can damage nerve cells in the brain. High levels of phenylalanine can result in signs and symptoms ranging from temporary low muscle tone to mental retardation, movement disorders, difficulty swallowing, seizures, behavioral problems, progressive problems with development, and an inability to control body temperature.
Conray 35 Absorption
No information avaliable
Conray 35 side effects and Toxicity
No information avaliable
Conray 35 Patient Information
No information avaliable
Conray 35 Organisms Affected
Humans and other mammals
